Risk factors for cardiac events in carfilzomib-treated patients in the Marketscan database (20160186)

First published 19/05/2016

Last updated 30/03/2024

EU PAS number:

EUPAS13518

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

Protocol for Marketscan CVD Events MM _05022016_final

English (634.73 KB - PDF)View document

Study results

Study results

Abstract 20160186_Carfilzomib_31May2017

English (122.9 KB - PDF)View document

Study report

Other information

ENCePP Seal

ENCePP Seal documents